SOD2 and ovarian cancer: For instance, miR-222 and miR-382 downregulate MnSOD in tongue cancer and under transforming growth factor beta signaling [169,170], while low miR-17 and miR-146a levels are associated with increased MnSOD and altered treatment responses in prostate and ovarian cancer [171,172,173].